Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06330701Not ApplicableCompleted

Stone Access and Removal (STAR) Study

Role: lead

NCT05835323Not ApplicableCompleted

Initial Clinical Experience With the MONARCH Platform, Urology for the Treatment of Kidney Stones

Role: lead

NCT04182815Completed

Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung

Role: lead

NCT05426213Not ApplicableWithdrawn

A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung Lesions

Role: lead

NCT03497026Not ApplicableTerminated

Auris Robotic Endoscopy System for Bronchoscopy

Role: lead

NCT03727425Not ApplicableCompleted

Robotic Bronchoscopy for Peripheral Pulmonary Lesions

Role: lead

All 6 trials loaded